GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » YoY EPS Growth

PixarBio (PixarBio) YoY EPS Growth : 100.00% (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. PixarBio's YoY EPS Growth for the quarter that ended in Sep. 2016 was 100.00%.

PixarBio's Earnings per Share (Diluted) for the three months ended in Sep. 2016 was $0.00.


PixarBio YoY EPS Growth Historical Data

The historical data trend for PixarBio's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio YoY EPS Growth Chart

PixarBio Annual Data
Trend Dec14 Dec15
YoY EPS Growth
- -

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 100.00 100.00

PixarBio YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

PixarBio's YoY EPS Growth for the fiscal year that ended in Dec. 2015 is calculated as:

YoY EPS Growth (A: Dec. 2015 )
=(Earnings per Share (Diluted) (A: Dec. 2015 )-Earnings per Share (Diluted) (A: Dec. 2014 ))/ | Earnings per Share (Diluted) (A: Dec. 2014 ) |
=(-0.002--0)/ | -0 |
=N/A %

PixarBio's YoY EPS Growth for the quarter that ended in Sep. 2016 is calculated as:

YoY EPS Growth (Q: Sep. 2016 )
=(Earnings per Share (Diluted) (Q: Sep. 2016 )-Earnings per Share (Diluted) (Q: Sep. 2015 )) / | Earnings per Share (Diluted) (Q: Sep. 2015 )) |
=(-0--0.001)/ | -0.001 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of PixarBio's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines